| |
 |
|
Class Information
Number: 424/143.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) > Binds receptor
Description: Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with a free or cell-associated receptor.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618630 |
Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
Nov. 17, 2009 |
| 7618631 |
Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs |
Nov. 17, 2009 |
| 7618633 |
Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses |
Nov. 17, 2009 |
| 7618626 |
Combination treatment for non-hematologic malignancies |
Nov. 17, 2009 |
| 7615210 |
Treatment of endometriosis |
Nov. 10, 2009 |
| 7615214 |
Anti-human VEGF receptor Flt-1 monoclonal antibody |
Nov. 10, 2009 |
| 7615215 |
Anti-human VEGF receptor Flt-1 monoclonal antibody |
Nov. 10, 2009 |
| 7615220 |
High affinity human antibodies to human IL-18 receptor |
Nov. 10, 2009 |
| 7611707 |
Glycoprotein VI antibodies and methods thereof |
Nov. 3, 2009 |
| 7611708 |
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
Nov. 3, 2009 |
| 7608264 |
Antibodies that bind to pleiotrophin growth factor receptor |
Oct. 27, 2009 |
| 7608269 |
Compositions and methods for treating cancer by modulating HER-2 and EGF receptors |
Oct. 27, 2009 |
| 7604799 |
EphA4 Antibodies |
Oct. 20, 2009 |
| 7604800 |
Anti-PSGL-1 antibodies |
Oct. 20, 2009 |
| 7605238 |
Human CTLA-4 antibodies and their uses |
Oct. 20, 2009 |
| 7597888 |
Glycoprotein VI and uses thereof |
Oct. 6, 2009 |
| 7597889 |
Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
Oct. 6, 2009 |
| 7595046 |
Treatment of cancer using anti-Apo-2 antibodies |
Sep. 29, 2009 |
| 7595045 |
Anti-.alpha.9 integrin antibody and the use thereof |
Sep. 29, 2009 |
| 7595051 |
Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies |
Sep. 29, 2009 |
| 7592007 |
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
Sep. 22, 2009 |
| 7592006 |
Composition comprising the LO-CD2a antibody |
Sep. 22, 2009 |
| 7592005 |
Monoclonal antibody |
Sep. 22, 2009 |
| 7582298 |
High affinity antibodies to human IL-6 receptor |
Sep. 1, 2009 |
| 7582610 |
Melanocortin receptor templates, peptides and use thereof |
Sep. 1, 2009 |
| 7575746 |
Modified human IGF-IR antibodies |
Aug. 18, 2009 |
| 7575742 |
Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist |
Aug. 18, 2009 |
| 7572768 |
Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
Aug. 11, 2009 |
| 7569224 |
Mammalian cytokines; receptors; related reagents and methods |
Aug. 4, 2009 |
| 7566450 |
Humanized anti-CCR2 antibodies and methods of use therefor |
Jul. 28, 2009 |
| 7563441 |
Anti-P-selectin antibodies |
Jul. 21, 2009 |
| 7563442 |
Antibodies to CD40 and methods of treating cancer and enhancing immune responses |
Jul. 21, 2009 |
| 7563443 |
Monovalent anti-CD40L antibody polypeptides and compositions thereof |
Jul. 21, 2009 |
| 7560111 |
HER2 antibody composition |
Jul. 14, 2009 |
| 7556804 |
Anti-HGF-R antibodies and their use |
Jul. 7, 2009 |
| 7557189 |
Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
Jul. 7, 2009 |
| 7553485 |
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof |
Jun. 30, 2009 |
| 7553936 |
Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions |
Jun. 30, 2009 |
| RE40811 |
Peripheralization of hematopoietic stem cells |
Jun. 30, 2009 |
| 7550142 |
Anti-integrin antibodies, compositions, methods and uses |
Jun. 23, 2009 |
| 7550143 |
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
Jun. 23, 2009 |
| 7547438 |
CD40-binding activating antibodies |
Jun. 16, 2009 |
| 7547437 |
Method of treating fibrosis |
Jun. 16, 2009 |
| 7544358 |
Treatment of acute lung injury, fibrosis and metastasis with antagonists of .alpha.v.beta.6 |
Jun. 9, 2009 |
| 7541029 |
Anti-rhesus D monoclonal antibodies |
Jun. 2, 2009 |
| 7541030 |
Antibodies for identifying and/or isolating at least one cell population which is selected from the group comprising haematopoietic stem cells, neuronal stem cells, neuronal precursor cells, m |
Jun. 2, 2009 |
| 7541032 |
Antigen uptake receptor for Candida albicans on dendritic cells |
Jun. 2, 2009 |
| 7541164 |
Mammalian cell culture processes for protein production |
Jun. 2, 2009 |
| 7541027 |
Use of an epitope of vascular endothelial growth factor receptor KDR/Flk-1 |
Jun. 2, 2009 |
| 7537763 |
Anti-CD40 monoclonal antibody |
May. 26, 2009 |
|
|
|
